{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T19:58:10Z","timestamp":1697054290959},"reference-count":0,"publisher":"American Physiological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"],"published-print":{"date-parts":[[1993,7,1]]},"abstract":"<jats:p> Experiments were undertaken to test whether oxytocin (OT) may modulate the antipyretic action of arginine vasopressin (AVP) and to determine whether the action of endogenously released OT and\/or AVP evoked by fever may modulate the motor actions of exogenous AVP. Intracerebroventricular (icv) injection of interleukin-1 alpha (IL-1 alpha, 40 ng) elicited a significantly attenuated rise in body temperature during the 2nd h of the febrile responses in OT-pretreated (0.1-10 pmol icv, 24 h earlier) rats. At the end of the 2nd h, administration of AVP (1 pmol icv), but not OT (10 pmol icv), significantly suppressed the febrile response in OT-pretreated but not in saline-pretreated rats. In nonfebrile OT-pretreated rats, 10 but not 1 pmol of AVP (icv) caused a significant decrease in body temperature. In rats pretreated with IL-1 alpha (40 ng icv) injection of AVP (100 pmol icv) induced enhanced motor responses. In summary, the ability of OT pretreatment to alter the febrile response to IL-1 alpha and the antipyretic action of AVP suggests a role for this peptide in fever. Furthermore, the observation that fever pretreatment can lower the threshold for convulsive-like behavior evoked by subsequent exposure to AVP raises the possibility that central OT and\/or AVP released during fever could play a role in the genesis of febrile convulsions. <\/jats:p>","DOI":"10.1152\/ajpregu.1993.265.1.r151","type":"journal-article","created":{"date-parts":[[2017,12,24]],"date-time":"2017-12-24T16:34:22Z","timestamp":1514133262000},"page":"R151-R156","source":"Crossref","is-referenced-by-count":5,"title":["Possible involvement of brain oxytocin in modulating vasopressin antipyretic action"],"prefix":"10.1152","volume":"265","author":[{"given":"P.","family":"Poulin","sequence":"first","affiliation":[{"name":"Department of Medical Physiology, University of Calgary, Alberta,Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q. J.","family":"Pittman","sequence":"additional","affiliation":[{"name":"Department of Medical Physiology, University of Calgary, Alberta,Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","container-title":["American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpregu.1993.265.1.R151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T22:46:26Z","timestamp":1567982786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpregu.1993.265.1.R151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,7,1]]}},"alternative-id":["10.1152\/ajpregu.1993.265.1.R151"],"URL":"https:\/\/doi.org\/10.1152\/ajpregu.1993.265.1.r151","relation":{},"ISSN":["0363-6119","1522-1490"],"issn-type":[{"value":"0363-6119","type":"print"},{"value":"1522-1490","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7,1]]}}}